Evolent Health Files 8-K on Financials
Ticker: EVH · Form: 8-K · Filed: May 8, 2025 · CIK: 1628908
| Field | Detail |
|---|---|
| Company | Evolent Health, INC. (EVH) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: EVH
TL;DR
EVH filed an 8-K, expect financial updates soon.
AI Summary
Evolent Health, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signals that Evolent Health is providing updated information regarding its financial performance and condition to the SEC and the public.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not inherently present new risks.
Key Players & Entities
- Evolent Health, Inc. (company) — Registrant
- May 8, 2025 (date) — Filing Date
- 1812 N. Moore Street, Suite 1705, Arlington, Virginia, 22209 (address) — Principal Executive Offices
FAQ
What specific financial results are being reported in this 8-K?
The provided text indicates the 8-K is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific results within this excerpt.
When was this 8-K filed with the SEC?
This 8-K was filed on May 8, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Evolent Health, Inc.
What is the principal executive office address for Evolent Health, Inc.?
The principal executive offices are located at 1812 N. Moore Street, Suite 1705, Arlington, Virginia, 22209.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding Evolent Health, Inc. (EVH).